526301 — Medinova Diagnostic Services Income Statement
0.000.00%
- IN₹414.24m
- IN₹439.14m
- IN₹101.65m
- 77
- 34
- 74
- 70
Annual income statement for Medinova Diagnostic Services, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 74.5 | 127 | 132 | 99.9 | 102 |
Cost of Revenue | |||||
Gross Profit | 63.6 | 112 | 107 | 87 | 91.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 72 | 105 | 100 | 77.2 | 75.1 |
Operating Profit | 2.44 | 22.9 | 31.6 | 22.7 | 26.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.76 | 19.6 | 28 | 19 | 22.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.28 | 19 | 23.8 | 16.7 | 20 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.58 | 20.2 | 22.7 | 16.7 | 20 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.58 | 20.2 | 22.7 | 16.7 | 20 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.259 | 2.03 | 2.27 | 1.67 | 2 |